Form 4 for IOVA IOVANCE BIOTHERAPEUTICS, INC.
Accepted 2022-06-16 00:00:00 ET · period of report 2022-06-14 · accession 0001104659-22-071964 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-16 | 2022-06-14 | IOVA | BILINSKY IGOR | COO | F - Tax | $7.73 | -9,346 | 9,504 | -50% | -$72.2K |
| D | 2022-06-16 | 2022-06-14 | IOVA | BILINSKY IGOR | COO | M - OptEx | $0.00 | +18.9K | 18.9K | New | $0 |
| D | 2022-06-16 | 2022-06-14 | IOVA | BILINSKY IGOR | COO | A - Grant | $0.00 | +18.9K | 18.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-14 | F | D | 9,346 | $7.73 | 9,504 | D | — | — | (F2) Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. (F3) Represents common stock remaining after deducting the common stock withheld for taxes. |
| 2 | Common | Common Stock | 2022-06-14 | M | A | 18,850 | $0.00 | 18,850 | D | — | — | (F1) This is the first vesting of the restricted stock units issued on June 14, 2021. |
| 3 | Derivative | Restricted Stock Units | 2022-06-14 | A | A | 18,850 | $0.00 | 18,850 | D | — · — to — | 18,850 Common stock | (F4) Represents restricted stock units remaining after deducting the vested shares of common stock and common stock withheld for taxes as set forth in Table I above. (F5) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F6) Provided the Reporting Person is still employed with the Issuer on December 31, 2022, the remaining restricted stock units shall vest and be settled on such date. |